Division of Infectious Disease and International Medicine.
J Infect Dis. 2014 May 15;209(10):1628-34. doi: 10.1093/infdis/jit671. Epub 2014 Jan 23.
Response to challenge with live, attenuated, oral polio vaccine (OPV) is a measure of immunity induced by prior immunization.
Using stool samples from a study from Oman in which an initial schedule of inactivated polio vaccine (IPV) was followed by an OPV type 1 challenge, we quantitated virus shed, sequenced capsid proteins of recovered virus, and developed assays for neutralization of poliovirus and mucosal immunoglobulin A (IgA) detection.
Neutralizing activity correlated with detection of polio-specific IgA in stool suspensions collected 7 days after OPV type 1 challenge. Both neutralization and IgA in stool were associated with cessation of virus shedding by day 7. Rapid development of an IgA response with cessation of shedding suggests that IPV primed for the early response to challenge. Correlation of neutralization activity and IgA detection provides evidence that polio-specific IgA intestinal antibody is a determinant of mucosal shedding/transmission and that IgA functions through neutralization of virus. In contrast, neither presence nor quantity of serum or intestinal antibody induced by IPV prior to challenge correlated with cessation of shedding.
These assays provide an opportunity to study other immunization schedules to gain a broader understanding of the appearance and duration of a protective mucosal response to polio vaccination.
对口服减毒活疫苗(OPV)的反应是衡量既往免疫所诱导免疫的一项指标。
我们使用来自阿曼一项研究的粪便样本,该研究中初始接种的是灭活脊髓灰质炎疫苗(IPV),随后进行了 OPV 1 型挑战。我们定量检测了病毒脱落情况、对回收病毒的衣壳蛋白进行测序,并开发了针对脊髓灰质炎病毒中和的检测方法和黏膜免疫球蛋白 A(IgA)检测方法。
中和活性与 OPV 1 型挑战后 7 天采集的粪便悬液中脊髓灰质炎特异性 IgA 的检测相关。中和活性和粪便中的 IgA 均与第 7 天停止病毒脱落相关。快速产生的 IgA 应答和病毒脱落停止提示 IPV 可引发对挑战的早期应答。中和活性和 IgA 检测的相关性为脊髓灰质炎特异性 IgA 肠道抗体是黏膜脱落/传播的决定因素,并且 IgA 通过中和病毒发挥作用提供了证据。相比之下,在挑战之前 IPV 诱导的血清或肠道抗体的存在或数量与病毒脱落停止均无相关性。
这些检测方法为研究其他免疫接种方案提供了机会,有助于更广泛地了解针对脊髓灰质炎疫苗接种的保护性黏膜应答的出现和持续时间。